Research output per year
Research output per year
Personal profile
Biography
Current positions
2018-present Associate Professor Oncological Urology, UMC Utrecht
2018-present Head Department Oncological Urology, UMC Utrecht Cancer Center
2012-present Oncological Urologist, University Medical Center Utrecht (UMCU), The Netherlands
2016-present Deputy Chief of the Specialist Medical Training Urology UMC Utrecht
2016-present Chairman of the Oncological Urology Tumour Group, UMCU Cancer Center
2016-present Member of the Oncology Committee, UMCU Cancer Center
2016-present Associate member of ERUS (EAU Robotic Urology Section)
2015-present Member of the Dutch Uro-Oncological Society (DUOS)
2015-present Member Workgroup Oncological Urology (WOU) of the Dutch Urological Association (Dutch: NVU)
2015 SKMS workgroup Laparoscopy and Robotic Surgery
2014-present Associate member of ESOU (EAU Section of Oncological Urology)
2011-present Editorial Board Dutch Journal of Urology (Dutch: Tijdschrift voor Urologie)
Prior positions
2010-2012 Fellowship Oncological Urology, NKI-AVL, Amsterdam, The Netherlands; Supervisor Prof. Dr. S. Horenblas
Oct 2009 Fellowship Laparoscopy, Universitäts Klinikum Leipzig, Germany; Supervisor Prof. Dr. J.U. Stolzenburg
2008-2009 Resident in Urology, University Medical Center Utrecht, The Netherlands; Supervisor Prof. Dr. J.L.H.R. Bosch
2006-2007 Resident in Urology, JBZ, ’s-Hertogenbosch; Supervisor Dr. H.P. Beerlage
2004-2005 Resident in Surgery, Diakonessenhuis Utrecht, Supervisor Dr. G.J. Clevers
Current research projects
Research support (institutional)
- Janssen (Research-grant) (2017-2022)
- Roche (Research-grant) (2017-2021)
- Astellas (Research-grant) (2021-2022)
- Merck (Educational-grant) (2022)
- Janssen/Astellas/AstraZeneca/MSD/BMS/Roche/Merck (ProBCI support) (2018---)
Company Advisory Boards (institutional):
- Merck
- MSD
- Janssen
- Bristol-Myers Squibb Company
2023 Framingham selection Urothelial Cancer Issues (Bristol-Myers Squibb Company; institutional)
Side activities
- Afdelingshoofd Oncologische Urologie
- Voorzitter UMC Utrecht Expertise Centrum voor testiculaire en extragonadale kiemceltumoren (Zaadbalkanker)
- Panellid EAU Richtlijn Spierinvasief en Gemetastaseerd Blaaskanker
- ProBCI Stuurgroep (probci.nl)
- BlaZIB Stuurgroep (Blaaskankerzorg in Beeld) (IKNL)
- Plaatsvervangend opleider Urologie UMCU
- Voorzitter tumorwerkgroep Oncologische Urologie UMCU
- Lid Oncologie commissie UMCU Cancer Center
- Lid Werkgroep Oncologische Urologie (WOU) van de NVU
- Associate member ESOU
- Associate member ERUS
External positions
Panelmember EAU Muscle-invasive and Metastatic Bladder Cancer (MIBC) Guidelines Panel - Aandachtsgebied blaaskanker - European Association of Urology
19 Mar 2021 → 31 Dec 3999
Panelmember EAU Guideline Primary Urethral Carcinoma - Europese richtlijn commissie - European Association of Urology
19 Mar 2021 → 31 Dec 3999
Stuurgroep ProBCI - Blaaskanker expertise - Stichting Prospectieve Blaaskanker Infrastructuur (ProBCI)
24 Oct 2019 → 31 Dec 3999
Plaatsvervangend opleider Urologie UMCU - Plaatsvervangend opleider Urologie UMCU - UMCU
12 Oct 2016 → 31 Dec 3999
Associate member of ERUS (EAU Robotic Urology Section) - Associate member of ERUS (EAU Robotic Urology Section) - European Association of Urology
15 Sept 2016 → 31 Dec 3999
Voorzitter UMC Utrecht Expertise Centrum voor testiculaire en extragonadale - Voorzitter UMC Utrecht Expertise Centrum voor testiculaire en extragonadale NFU accreditatie (ECZA) - UMCU
6 Jul 2016 → 31 Dec 3999
Lid van Dutch Uro-Oncological Society (DUOS) - Actief lid van de subgroepen blaaskanker en zaadbalkanker van de DUOS - Dutch Uro-Oncological Society (DUOS)
16 Sept 2015 → 31 Dec 3999
Lid Werkgroep Oncologische Urologie (WOU) van de NVU - Actief lid van de subgroepen blaaskanker en zaadbalkanker van de Werkgroep Oncologische Urologie (WO - Nederlandse Vereniging voor Urologie
15 Jul 2015 → 31 Dec 3999
Associate member of ESOU (EAU Section of Oncological Urology) - Associate member of ESOU (EAU Section of Oncological Urology) - European Association of Urology
13 May 2014 → 31 Dec 3999
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial (Nature Medicine, (2023), 29, 3, (588-592), 10.1038/s41591-022-02199-y)
van Dorp, J., Pipinikas, C., Suelmann, B. B. M., Mehra, N., van Dijk, N., Marsico, G., van Montfoort, M. L., Hackinger, S., Braaf, L. M., Amarante, T., van Steenis, C., McLay, K., Daletzakis, A., van den Broek, D., van de Kamp, M. W., Hendricksen, K., de Feijter, J. M., Boellaard, T. N., Meijer, R. P. & van der Heijden, A. G. & 4 others, , Jan 2024, In: Nature Medicine. 30, 1, p. 304 1 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Open AccessFile -
Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines” [Eur. Urol. 85 (2024) 17–31, (S0302283823030737), (10.1016/j.eururo.2023.08.016)]
Alfred Witjes, J., Bruins, H. M., Carrión, A., Cathomas, R., Compérat, E., Efstathiou, J. A., Fietkau, R., Gakis, G., Lorch, A., Martini, A., Mertens, L. S., Meijer, R. P., Milowsky, M. I., Neuzillet, Y., Panebiaco, V., Redlef, J., Rink, M., Rouanne, M., Thalmann, G. N. & Sæbjørnsen, S. & 3 others, , Jun 2024, In: European Urology. 85, 6, e180.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
-
Disease-free survival of patients with muscle invasive bladder cancer treated with radical cystectomy versus bladder preserving therapy: a nationwide study
1 Jan 2024, In: International journal of radiation oncology, biology, physics. 118, 1, p. 41-49 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
Alfred Witjes, J., Max Bruins, H., Carrión, A., Cathomas, R., Compérat, E., Efstathiou, J. A., Fietkau, R., Gakis, G., Lorch, A., Martini, A., Mertens, L. S., Meijer, R. P., Milowsky, M. I., Neuzillet, Y., Panebianco, V., Redlef, J., Rink, M., Rouanne, M., Thalmann, G. N. & Sæbjørnsen, S. & 2 others, , Jan 2024, In: European Urology. 85, 1, p. 17-31 15 p.Research output: Contribution to journal › Review article › peer-review
-
Perspectives and Concerns on Late Effects Regarding Sexuality among Adolescents and Young Adults Treated for Testicular Germ Cell Tumor: The PRICELESS-Study-A Qualitative Study
Kuiper, S. T., Zweers, D., Suelmann, B. B. M., Meijer, R. P. & Vervoort, S. C. J. M., 8 Feb 2024, In: Cancers. 16, 4, 715.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure)
Activities
-
Global Congress on Bladder Cancer 2022
Richard Meijer (Invited speaker)
20 Oct 2022Activity: Participating in or organising an event › Participation in workshop, seminar, course › Academic
-
Neoadjuvant/inductie systemische behandeling gevolgd door blaassparende behandeling
Richard Meijer (Speaker)
22 Apr 2022Activity: Talk or presentation › Invited talk › Professional
-
-Complications after RC and management -Ureter/bowel anastomosis strictures: video’s reimplantation versus endo dilatation
Richard Meijer (Speaker)
8 Apr 2022Activity: Talk or presentation › Invited talk › Academic
-
Urothelial cancer organoids: a tool for bladder cancer research
Richard Meijer (Speaker)
10 Jun 2021Activity: Talk or presentation › Invited talk › Academic
-
European Association of Urology (External organisation)
Richard Meijer (Member)
19 Mar 2021Activity: Membership › Membership of guideline committee › Professional